MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.healun.2018.06.004

Медицинская библиотека · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2018

Impact of body mass index on adverse events after implantation of left ventricular assist devices: An IMACS registry analysis.

Forest Stephen J, Xie Rongbing, Kirklin James K, Cowger Jennifer, Xia Yu, Dipchand Anne I, Sivathasan Cumara, Merry Chris, Lund Lars H, Kormos Robert, Hannan Margaret M, Nakatani Takeshi, Jorde Ulrich, Goldstein Daniel J

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Limited data exist describing impact of body mass index (BMI) on post‒left ventricular assist device (post-LVAD) outcomes. We sought to define the relationship between body mass index (BMI) and adverse events (AEs) after LVAD implantation by examining the ISHLT Mechanically Assisted Circulatory Support (IMACS) registry.

METHODS

Patients implanted with a contemporary continuous flow (CF)-LVAD were stratified into 4 groups using pre-operative BMI: underweight (UW; BMI ≤18.5 kg/m2); non-obese (NO; BMI >18.5 to <30 kg/m2); obese (OB; BMI ≥30 to <40 kg/m2); and morbidly obese (MO; BMI ≥40 kg/m2). Freedom from AEs was evaluated using the Kaplan-Meier method and risk factors for development of first AE were identified using multiphase parametric hazard modeling. AEs included infection, thromboembolic events, bleeding, device malfunction, and neurologic dysfunction.

RESULTS

Between 2013 and 2015, a total of 9,408 patients underwent implantation of a CF-LVAD, which consisted of 368 (4%) UW, 5,719 (61%) NO, 2,770 (29%) OB, and 444 (5%) MO patients. Survival among the 4 BMI cohorts was similar at 2years (70.8% to 75.8%, p = 0.24). MO patients were less likely to be free from a non‒VAD-related infection (p < 0.0001) or device-related infection (p = 0.0014) at 2years (50.3%, 70.7%) when compared with OB (58.3%, 78.7%), NO (65.2%, 81.4%), and UW (68.9%, 77.4%) patients. UW (81.5%) and NO (81.3%) patients were more likely to be free from device malfunction at 2years when compared with OB (78.3%) and MO (72.6%) (p = 0.0006). Thromboembolic events were rare and more common in the UW cohort (p = 0.026).

CONCLUSIONS

Although BMI was not correlated with 2-year mortality, an increased rate of infectious and device-related AEs was noted in OB and MO LVAD patients. In a group with few options for transplant, the event morbidity in obese patients can be expected to impact morbidity with longer support durations.

Для цитирования: Forest Stephen J, Xie Rongbing, Kirklin James K, Cowger Jennifer, Xia Yu, Dipchand Anne I, Sivathasan Cumara, Merry Chris, Lund Lars H, Kormos Robert, Hannan Margaret M, Nakatani Takeshi, Jorde Ulrich, Goldstein Daniel J. Impact of body mass index on adverse events after implantation of left ventricular assist devices: An IMACS registry analysis.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018. DOI: 10.1016/j.healun.2018.06.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.